3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
34
Phase 2
31
Phase 1/2
18
Phase 3
6
Phase 2/3
4
Phase 4
3
Phase NA
1
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
15
Other solid neoplasm
3
Tumor-Agnostic
2
Other neoplasm
1
Conditions
Mesothelioma
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
Pemetrexed
3
sacituzumab govitecan
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
encorafenib
1
binimetinib
1
Vincristine
1
Sunitinib
1
Sirolimus
1
Raltegravir Potassium
1
Paclitaxel
1
One-Lung Ventilation
1
Midazolam
1
Leucovorin
1
Itraconazole
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Drug Therapy
1
Clinical Trials, Phase I as Topic
1
Cetuximab
1
Carboplatin
1
Bevacizumab
1
Anesthesia, General
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Pemetrexed
×
Other solid neoplasm
×
Clear all
NCT03656549
2024-12-17
IMPROVE-I
Radboud University Medical Center
Phase 4
Completed
6 enrolled
NCT03655821
2022-05-13
IMPROVE-II
Radboud University Medical Center
Phase 4
Terminated
81 enrolled
NCT03655834
2022-05-10
IMPROVE-III
Radboud University Medical Center
Phase 4
Completed
10 enrolled